UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 31

Sortiert nach

Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients

Journal of lipid research, 2000-02, Vol.41 (2), p.195-198

2000

Volltextzugriff (PDF)

Serum levels and cardiovascular effects of Tricyclic antidepressants and selective serotonin reuptake inhibitors in depressed patients

Therapeutic drug monitoring, 2001-08, Vol.23 (4), p.435-440

2001

Volltextzugriff (PDF)

Steady state concentrations of clomipramine and its major metabolite desmethylclomipramine in rat brain and serum after oral administration of clomipramine

European neuropsychopharmacology, 2000-09, Vol.10 (5), p.401-405

2000

Volltextzugriff (PDF)

Allelic association between the D10S1423 marker and Alzheimer's disease in a German population

Neuroscience letters, 2000-08, Vol.289 (3), p.224-226

2000

Volltextzugriff (PDF)

Pharmacokinetic-pharmacodynamic modeling of tolerance to the prolactin-secreting effect of chlorprothixene after different modes of drug administration

The Journal of pharmacology and experimental therapeutics, 1999-11, Vol.291 (2), p.547

1999

Volltextzugriff (PDF)

Polymorphisms of the gene encoding the inflammatory cytokine interleukin-6 determine the magnitude of the increase in soluble interleukin-6 receptor levels in Alzheimer's disease

European archives of psychiatry and clinical neuroscience, 2003-02, Vol.253 (1), p.44-48

2003

Volltextzugriff (PDF)

A genetic variation of the inflammatory cytokine interleukin-6 delays the initial onset and reduces the risk for sporadic Alzheimer's disease

Annals of neurology, 1999-05, Vol.45 (5), p.666-668

1999

Volltextzugriff (PDF)

Plasma 24S-hydroxycholesterol: a peripheral indicator of neuronal degeneration and potential state marker for Alzheimerʼs disease

Neuroreport, 2000-06, Vol.11 (9), p.1959-1962

2000

Volltextzugriff (PDF)

A genetic variation of cathepsin D is a major risk factor for Alzheimer's disease

Annals of neurology, 2000-03, Vol.47 (3), p.399-403

2000

Volltextzugriff (PDF)

Association between an interleukin-6 promoter and 3′ flanking region haplotype and reduced Alzheimer's disease risk in a German population

Neuroscience letters, 2000-04, Vol.283 (2), p.109-112

2000

Volltextzugriff (PDF)

Genetic polymorphism of cathepsin D is strongly associated with the risk for developing sporadic Alzheimer's disease

Neuroscience letters, 1999-03, Vol.262 (3), p.171-174

1999

Volltextzugriff (PDF)

Gene polymorphisms of interleukin-1α influence the course of Alzheimer's disease

Annals of neurology, 2001-06, Vol.49 (6), p.818-819

2001

Volltextzugriff (PDF)

Cerebrospinal fluid levels of β-amyloid(42) in patients with Alzheimerʼs disease are related to the exon 2 polymorphism of the cathepsin D gene

Neuroreport, 2002-07, Vol.13 (10), p.1291-1294

2002

Volltextzugriff (PDF)

Persistently increased density of serotonin transporters in the frontal cortex of rats treated with fluoxetine during early juvenile life

Journal of child and adolescent psychopharmacology, 1999, Vol.9 (1), p.13-24

1999

Volltextzugriff (PDF)

Polymorphisms of the gene encoding the inflammatory cytokine interleukin-6 determine the magnitude of the increase in soluble interleukin-6 receptor levels in Alzheimer's disease. Results of a pilot study

European archives of psychiatry and clinical neuroscience, 2003-02, Vol.253 (1), p.44-48

2003

Volltextzugriff (PDF)

Gene-gene interaction between interleukin-6 and α2-macroglobulin influences the risk for Alzheimer's disease

Annals of neurology, 2000-01, Vol.47 (1), p.138-139

2000

Volltextzugriff (PDF)

No association of serum levels of interleukin-6 and its soluble receptor components with a genetic variation in the 3'flanking region of the interleukin-6 gene in patients with multiple sclerosis

Neuroscience letters, 2000-11, Vol.294 (3), p.139-142

2000

Volltextzugriff (PDF)

Cerebrospinal fluid levels of ??-amyloid(42) in patients with Alzheimer??s disease are related to the exon 2 polymorphism of the cathepsin D gene

Neuroreport, 2002-07, Vol.13 (10), p.1291-1294

2002

Volltextzugriff (PDF)

No association of serum levels of interleukin-6 and its soluble receptor components with a genetic variation in the 3′flanking region of the interleukin-6 gene in patients with multiple sclerosis

Neuroscience letters, 2000-11, Vol.294 (3), p.139-142

2000

Volltextzugriff (PDF)

Gene-gene interaction between interleukin-6 and ?2-macroglobulin influences the risk for Alzheimer's disease

Annals of neurology, 2000-01, Vol.47 (1), p.138-139

2000

Volltextzugriff (PDF)

Early-onset and late-onset depression are independent of the genetic polymorphism of apolipoprotein E

Dementia and geriatric cognitive disorders, 1999-07, Vol.10 (4), p.258

1999

Volltextzugriff (PDF)

An exonic polymorphism of the cathepsin D gene is a major risk factor for Alzheimer's disease

Neurobiology of aging, 2000-05, Vol.21, p.104-104

2000

Volltextzugriff (PDF)

Cathepsin D: screening for new polymorphisms using single-strand conformation polymorphism analysis

International journal of molecular medicine, 2002-02, Vol.9 (2), p.185

2002

Volltextzugriff (PDF)

Plasma 24S-hydroxycholesterol (cerebrosterol): An indicator of neuronal degeneration and potential state marker for dementia

Neurobiology of aging, 2000-05, Vol.21, p.22-22

2000

Volltextzugriff (PDF)

Alpha-1-antichymotrypsin gene polymorphism and risk for sporadic Alzheimer's disease in a German population

Dementia and geriatric cognitive disorders, 1999-11, Vol.10 (6), p.469

1999

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(31)

Sprache

Englisch
(31)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients

Serum levels and cardiovascular effects of Tricyclic antidepressants and selective serotonin reuptake inhibitors in depressed patients

Steady state concentrations of clomipramine and its major metabolite desmethylclomipramine in rat brain and serum after oral administration of clomipramine

Allelic association between the D10S1423 marker and Alzheimer's disease in a German population

Pharmacokinetic-pharmacodynamic modeling of tolerance to the prolactin-secreting effect of chlorprothixene after different modes of drug administration

Polymorphisms of the gene encoding the inflammatory cytokine interleukin-6 determine the magnitude of the increase in soluble interleukin-6 receptor levels in Alzheimer's disease

A genetic variation of the inflammatory cytokine interleukin-6 delays the initial onset and reduces the risk for sporadic Alzheimer's disease

Plasma 24S-hydroxycholesterol: a peripheral indicator of neuronal degeneration and potential state marker for Alzheimerʼs disease

A genetic variation of cathepsin D is a major risk factor for Alzheimer's disease

Association between an interleukin-6 promoter and 3′ flanking region haplotype and reduced Alzheimer's disease risk in a German population

Genetic polymorphism of cathepsin D is strongly associated with the risk for developing sporadic Alzheimer's disease

Gene polymorphisms of interleukin-1α influence the course of Alzheimer's disease

Cerebrospinal fluid levels of β-amyloid(42) in patients with Alzheimerʼs disease are related to the exon 2 polymorphism of the cathepsin D gene

Persistently increased density of serotonin transporters in the frontal cortex of rats treated with fluoxetine during early juvenile life

Polymorphisms of the gene encoding the inflammatory cytokine interleukin-6 determine the magnitude of the increase in soluble interleukin-6 receptor levels in Alzheimer's disease. Results of a pilot study

Gene-gene interaction between interleukin-6 and α2-macroglobulin influences the risk for Alzheimer's disease

No association of serum levels of interleukin-6 and its soluble receptor components with a genetic variation in the 3'flanking region of the interleukin-6 gene in patients with multiple sclerosis

Cerebrospinal fluid levels of ??-amyloid(42) in patients with Alzheimer??s disease are related to the exon 2 polymorphism of the cathepsin D gene

No association of serum levels of interleukin-6 and its soluble receptor components with a genetic variation in the 3′flanking region of the interleukin-6 gene in patients with multiple sclerosis

Gene-gene interaction between interleukin-6 and ?2-macroglobulin influences the risk for Alzheimer's disease

Early-onset and late-onset depression are independent of the genetic polymorphism of apolipoprotein E

An exonic polymorphism of the cathepsin D gene is a major risk factor for Alzheimer's disease

Cathepsin D: screening for new polymorphisms using single-strand conformation polymorphism analysis

Plasma 24S-hydroxycholesterol (cerebrosterol): An indicator of neuronal degeneration and potential state marker for dementia

Alpha-1-antichymotrypsin gene polymorphism and risk for sporadic Alzheimer's disease in a German population

Suchergebnisse filtern